Stay updated on Durvalumab + Tremelimumab in Head and Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab + Tremelimumab in Head and Neck Cancer Clinical Trial page.

Latest updates to the Durvalumab + Tremelimumab in Head and Neck Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedEnrollment status updated to 'No longer looking for participants', indicating the study is not actively enrolling. New help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) were added, and the Intervention/Treatment heading was updated from 'Intervention / Treatment' with an accompanying Revision: v3.6.0 tag.SummaryDifference0.4%

- Check15 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5. This indicates a minor behind-the-scenes update to the page without changing study information.SummaryDifference0.0%

- Check37 days agoChange DetectedThe page now shows a newer revision tag, Revision: v3.5.4, replacing Revision: v3.5.3. This signals a small backend or QC update to the page rather than a change to the study information.SummaryDifference0.0%

- Check51 days agoChange DetectedThe revision label on the page changed from v3.5.2 to v3.5.3, indicating a software update to the page. It updates the version identifier displayed to users.SummaryDifference0.0%

- Check65 days agoChange DetectedRevision: v3.5.2 is now displayed on the page, replacing the previous Revision: v3.5.0.SummaryDifference0.0%

- Check87 days agoChange DetectedPage revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Durvalumab + Tremelimumab in Head and Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab + Tremelimumab in Head and Neck Cancer Clinical Trial page.